DHANUKA Dhanuka Agritech Q2 FY26 results (Jul–Sep 2025) and concall
Dhanuka Agritech reported a challenging Q2 FY26, with significant declines in revenue, EBITDA, and PAT, primarily due to adverse weather conditions impacting agrochemical demand and new biostimulant regulations. While new product development at the Dahej plant is progressing, sales guidance for acquired Bayer products was revised downwards due to registration delays. Management anticipates a better H2 FY26 with 2-3% growth, aiming for flattish annual revenue, and remains committed to backward integration and strategic acquisitions.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue down 8.6%, net profit down 20.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 654 | 445 | 442 | 528 | 598 −9% |
| EBITDA | 160 | 76 | 110 | 83 | 137 −14% |
| Net profit | 118 | 55 | 76 | 56 | 94 −20% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
